Patent Assignment
Reel/Frame 026101/0387
Change of Name
Recorded: 2011-04-08
Pages: 18
Assignor
HANALL PHARMACEUTICAL CO., LTD.
Executed: 2010-03-19
Assignee
HANALL BIOPHARMA CO., LTD.
400-1 SANGSEO-DONG, DAEDEOK-GU, DAEJEON, KOREA, REPUBLIC OF
Covered Property
(1)
Controlled Release Complex Composition Comprising Angiotensin-Ii-Receptor Blockers and Hmg-Coa Reductase Inhibitors
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.